Helaxy (Seed)

Funding Details

Awarder: Gaingels
Date Award: May 24, 2024
Vertical: Healthcare and Biotech
Funding URL: View Funding Page
Valuation: $17,000,000

Company Info

Founders: Michael Tillmann
Company Description: Helaxy specializes in fluidic cards which enables clinicians with minimal hands-on time to eliminate manual pipetting errors. Helaxy specializes in fluidic cards which enables clinicians with minimal hands-on time to eliminate manual pipetting errors
Market: Healthcare & Wellness
Coinvestors: Novalis Capital,Novalis LifeSciences

Links

Back to Home Back to Healthcare and Biotech Deals View Funding Announcement